Diphtheria Tetanus Pertussis Hepatitis B and Haemophilus influenzae type b Conjugate Vaccine
Diphtheria, tetanus, pertussis, hepatitis B and (+) Haemophilus influenzae type b conjugate vaccine (adsorbed)
Product Details
WHO Product ID
FVP-P-204
Status
Prequalified
Date of prequalification
Vaccine type
Diphtheria, tetanus, pertussis, hepatitis B and (+) Haemophilus influenzae type b conjugate vaccine (adsorbed)
Abbreviated Name
DTwP-HepB+Hib
Commercial Name
Diphtheria Tetanus Pertussis Hepatitis B and Haemophilus influenzae type b Conjugate Vaccine
PQ Holder
Serum Institute of India Pvt. Ltd.
212/2 Off Soli Poonawala Road, Hadaspar
Pune,
Maharashtra
411 028
India
Responsible NRA
Central Drugs Standard Control Organization (CDSCO)
Product description
Pharmaceutical Form
Lyophilised active component to be reconstituted with liquid active component before use
Presentation
Vial + Ampoule
Number of doses
10
Route of administration
Intramuscular
Vaccine Vial Monitor
Type 14
Multidose Vial Policy
WHO recommends that opened vials of this vaccine should be discarded 6 hours after opening or at the end of the immunization session, whichever comes first.
Shelf life (months)
24 months
Storage temperature
2 - 8°C
Diluent
Liquid active component
Preservative
Thiomersal
Preservative concentration
0.01%
Product Packaging
Secondary Container
Tertiary Container
Component Packed
Active (Vaccine)
Total doses
50
Description
Carton (containing 3x50= 150 vials of Hib component [Dimensions 18.5x9.x6.0 cm] and
Dimensions
18.5 x 9.0 x 6.0 cm
Cold Chain Volume (cm³/dose)
0.67
Component Packed
Active (Vaccine)
Total doses
50
Description
Carton containing 3x50= 150 vials of DTPwHepB component [Dimensions 18.5x9.5x6.0 cm])
Dimensions
18.5 x 9.5 x 6.0 cm
Cold Chain Volume (cm³/dose)
0.7
